Remote endarterectomy for occlusive iliac and superficial femoral artery disease

Future Cardiology

Volumn 3, Issue 1, 2007, Pages 43-51

  Smeets, Luuk ^a   Ho, Gwan H ^b   Moll, Frans L ^c  

^a TWENTEBORG HOSPITAL   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endarterectomy; Gangrene; Iliac artery; Intermittent claudication; Ischemia; Minimally invasive surgical procedures; Peripheral vascular disease; Popliteal artery; Superficial femoral artery; Vascular surgical procedure

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COUMARIN DERIVATIVE; DIPYRIDAMOLE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PACLITAXEL; RAPAMYCIN;

ANEURYSM; ARTERIOTOMY; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CLINICAL TRIAL; CORONARY STENT; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDARTERECTOMY; FEMORAL ARTERY; HUMAN; ILIAC ARTERY OBSTRUCTION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MINIMALLY INVASIVE SURGERY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RADIOLOGY; RESTENOSIS; RISK ASSESSMENT; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33846526640     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.3.1.43     Document Type: Article

References (54)

1. TASC Working group: D4 treatment of critical limb ischaemia Trans-Atlantic Inter-Society Consensus (TASC). J. Vasc. Surg. 31, S1-S289 (2000).
2. Ho GH: Endovascular remote endarterectomy: initial experience with a new technique in the treatment of superficial femoral artery occlusive disease. Thesis, Utrecht, The Netherlands, ISBN 90-393-2010-1 (1999).
3. Green RM, Abbot WM, Matsumoto T et al: Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J. Vasc. Surg. 31, 417-425 (2000).
4. Johnson WC, Lee KK: A comparative evaluation of polytetrafluorethylene, umbilical vein and saphenous vein bypass graft for femoral-popliteal above knee revascularization. A prospective randomized department of veterans affairs cooperative study. J. Vasc. Surg. 32, 268-277 (2000).
5. Klinkert P, Schepers A, Burger DC, van Bockel JH, Breslau PJ: Vein versus polytetrafluorethylene in above-knee femoropopliteal bypass grafting: five year results of a randomized control trial. J. Vasc. Surg. 37, 149-155 (2003).
6. Klinkert P, Oost PN, Breslau PJ, van Bockel JH: Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of literature. Eur. J. Vasc. Endovasc. Surg. 27, 357-362 (2004).
7. Devine C, McCollum C, on behalf of The North West Femoro-Popliteal Trial Participants: Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J. Vasc. Surg. 40, 924-931 (2004).
8. Hamsho A, Nott D, Harris PL: Prospective randomized trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass. Eur. J. Vasc. Endovasc. Surg. 17, 197-201 (1999).
9. Rutherford RB, Baker JD, Ernst C et al.: Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 26, 517-518 (1997).
10. Ho GH, van Buren PA, Moll FL, van der Bom JG, Eikelboom BC: The importance of revision of early restenosis after endovascular remote endarterectomy in SFA occlusive disease. Eur. J. Vasc. Endovasc. Surg. 19(1), 35-42 (2000).
11. Martin JD: Presented at: 29th Annual Meeting of the Southern Association for Vascular Surgery. Marco Island, FL, USA, 19-22 January (2005).
12. Rosenthal D, Schubart PJ, Kinney EV et al.: Remote superficial femoral artery endarterectomy: multicentre medium-term results. J. Vasc. Surg. 43, 428-432 (2001).
13. Galland RB, Whiteley MS, Gibson M, Simmons MJ, Torrie EP, Magee TR: Remote superficial femoral artery endarterectomy: medium-term results. Eur. J. Vasc. Surg. 19, 278-282 (2000).
14. Nelson PR, Powell RJ, Proia RR et al: Results of endovascular superficial femoral endarterectomy. Vasc. Surg. 34(3), 526-531 (2001).
15. Ho GH, Moll FL, Joosten PP, van de Pavoordt ED, Overtoom TT: The MollRing Cutter remote endarterectomy: preliminary experience with a new endovascular technique for treatment of occlusive superficial femoral artery disease. J. Endovasc. Surg. 2(3), 278-287 (1995).
16. Smeets L, de Borst GJ, de Vries JPPM, van den Berg JC, Ho GH, Moll FL: Remote iliac artery endarterectomy: seven year results of a less invasive technique for occlusive iliac artery disease. J. Vasc. Surg. 38, 1297-1304 (2003).
17. van den Dungen JJ, Boontje AH, Kropveld A: Unilateral iliofemoral occlusive disease: Long-term results of the semiclosed endarterectomy with the ringstripper. J. Vasc. Surg. 14, 673-677 (1991).
18. Bell DD, Gaspar MR, Movius HJ, Rosental JJ, Lemic GG: Retroperitoneal exposure of the terminal aorta and iliac arteries. Am. J. Surg. 138, 254-256 (1979).
19. Smeets L, Ho GH, Hagenaars T, van den Berg JC, Teijink JA, Moll FL: Remote endarterectomy: first choice in surgical treatment of long segmental SFA occlusive disease? Eur. J. Vasc. Endovasc. Surg. 25, 583-589 (2003).
20. Piotrowski JJ, Pearce WH, Jones DN et al: Aortobifemoral bypass: the operation of choice for unilateral iliac occlusion? J. Vasc. Surg. 8, 211-218 (1988).
21. Oliviera M, Wilson E, Williams R, Freischlag JA: Iliofemoral bypass: a 10-year review. Cardiovasc. Surg. 1(2), 103-106 (1993).
22. Naylor AR, Ah-See AK, Engeset J: Graft occlusion following aortofemoral bypass for peripheral ischemia. Br. J. Surg. 76, 572-575 (1989).
23. Schouten O, Hoedt MT, Wittens CH, Hop WC, van Sambeek MR, van Urk H, on behalf of the VASCAN study group: End-to-end versus end-to-side distal anastomosis in femoropopliteal bypasses; results of a randomized multicenter trial. Eur. J. Vasc. Endovasc. Surg. 29, 457-462 (2005).
24. Berglund J, Björck M, Elfström J, on behalf of the SWEDVASC Femoro-popliteal Study Group: Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur. J. Vasc. Endovasc. Surg. 29, 412-418 (2005).
25. Smeets L, Ho GH, Tangelder MJD et al., on behalf of the Dutch BOA study group: Outcome after occlusion of infrainguinal bypasses in the Dutch BOA study: comparison of amputation rate in venous and prosthetic grafts. Eur. J. Vasc. Endovasc. Surg. 30(6), 604-609 (2005).
26. Ballotta E, Renon L, Toffano M, Da Giau G: Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft verses reversed saphenous vein. J. Vasc. Surg. 38, 1051-1055 (2003).
27. Jackson MR, Belott TP, Dickason T et al.: The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. J. Vasc. Surg. 32(3), 498-505 (2000).
28. AbuRahma AF, Robinson PA, Holt SM: Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 126, 594-601 (1999).
29. van der Heijden FH, Eikelboom BC, van Reedt Dortland RW, van der Graaf P: Superficial femoral artery and the outcome of failed reconstructions. J. Vasc. Surg. 8, 271-279 (1993).
30. John TG, Stonebridge PA, Kelman J, Murie JA, Jenkins AM, Ruckley CV: Above-knee femoropopliteal bypass grafts and the consequence of graft failure. Ann. Royal Coll. Surg. Engl. 75, 257-260 (1993).
31. O'Riordain DS, Buckley DJ, O'Donnel JA: Polytetrafluoroethylene in above knee arterial bypass surgery for critical ischemia Am. J. Surg. 164, 129-131 (1992).
32. Blankensteijn JD, Van Vroonhoven TJ: Consequences of failure of femoropopliteal grafts for claudication. Eur. J. Vasc. Surg. 2, 183-189 (1988).
33. Brewster DC, LaSalle AJ, Robinson JG, Strayhom EC, Darling RC: Femoropopliteal graft failures. Arch. Surg. 118, 1043-1047 (1983).
34. Klein WM, van der Graaf Y, Seegers J, Moll FL, Mali WP: Long-term cardiovascular morbididty and mortality after endovascular treatment in patients with iliac artery disease: the Dutch Iliac Stent Trial Study. Radiology 232(2), 491-498 (2004).
35. Ng RI, Davies AH, Magee TR, Tennant S, Horrocks M, Baird RN: Early reoperation rates after arterial surgery. Eur. J. Vasc. Surg. 8(1), 78-82 (1994).
36. Kagan SA, Myers SI: Mediators of restenosis. Surg. Clin. North Am. 78, 481-500 (1998).
37. Leite PF, Liberman M, Sandoli de Brito F, Laurindo FR: Redox processes underlying the vascular repair reaction. World J. Surg. 28, 331-336 (2004).
38. Azevedo LC, Pedro MA, Souza LC et al.: Oxidative stress as a signalling mechanism of the vascular response to injury: the redox hypotheis of restenosis. Cardiovasc. Res. 47, 436-445 (2000).
39. Freyschuss A, Stiko-Rahm A, Swedenborg J et al.: Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J. Clin. Invest. 191, 1282-1288 (1993).
40. Bandoh T, Mitani H, Niihashi M et al.: Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition. J. Cardiovasc. Pharmacol. 35(1), 136-144 (2000).
41. Jacob T, Ascher E, Alapat D, Olevskaia Y, Hingorani A: Activation of p38MAPK signaling cascade in a VSMC injury model: role of p38MAPK inhibitors in limiting VSMC proliferation. Eur. J. Vasc. Endovasc. Surg. 29, 470-478 (2005).
42. Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, London NJ: Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J. Vasc. Surg. 36, 150-157 (1996).
43. Deng YM, Wu BJ. Witting PK, Stocker R: Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110(13), 1855-1860 (2004).
44. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J: Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 29, 171-176 (2005).
45. Goldman C, Salenius JP, Schmieder FA, Pilsudski R: Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a Phase I trial. J. Vasc. Surg. 35(5), 930-936 (2002).
46. Lederman RJ, Mendelsohn FO, Anderson RD et al.: TRAFFIC investigators. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359(9323), 2053-2058 (2002).
47. Arts CHP, de Groot PG, Slaper-Cortenbach ICM et al.: Research protocol "endothelial cell lining on prosthetic shunts evaluation (ECLIPSE-study)". Thesis CHP Arts, Utrecht, The Netherlands, ISBN 90-393-3187-1 (2002).
48. Knight JS, Smeers L, Morris GE, Moll FL: Multi centre study to assess the feasibility of a new covered stent and delivery system in combination with remote superficial femoral artery endarterectomy (RSFAE). Eur. J. Vasc. Endovasc. Surg. 29, 287-294 (2005).
49. Rosenthal D, Martin JD, Smeets L et al.: Remote superficial femoral artery endarterectomy and distal aSpire stenting: results of a multinational study at three year follow-up. J. Cardiovasc. Surg. (Torino) 47(4), 385-391 (2006).
50. Cheneau E. Rha SW, Kuchulakanti PK et al.: Impact of sirolimus-eluting stents'on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc. Interv. 65(4), 469-472 (2005).
51. Grube E, Silber S, Haubtmana KE et al.: Two-year plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I). Am. J. Cardiol. 96(1), 79-82 (2005).
52. Duda SH, Bosiers M, Lammer J et al.: Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J. Vasc. Interv. Radiol. 16(3), 331-338 (2005).
53. Blanchemain N, Haulon S, Martel B, Traisnel M, Morcellet M, Hildebrand HF: Vascular PET prostheses surface modification with cycodextrin coating: development of a new drug delivery system. Eur. J. Vas. Endovasc. Surg. 29, 628-632 (2005).
54. Hou D, Narciso H, Kamdar K, Zhang P, Barclay B, March KL: Stent-based nitric-oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model. Cardiovasc. Intervent. Radiol. 28(1), 60-65 (2005).